Dwarfism (Growth Hormone Deficiency) Medication Savings with TheDrugClub
Members can check active-formulary eligibility and membership pricing for Dwarfism (Growth Hormone Deficiency) medications. A condition association alone does not establish coverage.
What Is Dwarfism (Growth Hormone Deficiency)?
Dwarfism (Growth Hormone Deficiency) is a medical condition that may require prescription treatment. Consult a healthcare professional about appropriate options.
Managing Dwarfism (Growth Hormone Deficiency) with TheDrugClub
Eligible medications linked to the active formulary may have no additional cost under listed supply, quantity, fill, and fulfillment limits. Other prescriptions may qualify for membership pricing. Confirm current terms before filling.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
About Dwarfism (Growth Hormone Deficiency)
Dwarfism due to growth hormone deficiency (GHD) is a condition where the body doesn't produce enough growth hormone, leading to slow growth and short stature. Managing GHD often requires costly daily medication. TheDrugClub offers a straightforward solution, helping individuals and families access significant savings on these vital prescriptions, making treatment more affordable.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
About Isolated growth hormone deficiency (from MedlinePlus Genetics)
MedlinePlus Genetics covers Dwarfism (Growth Hormone Deficiency) in its summary of Isolated growth hormone deficiency.
Isolated growth hormone deficiency is a condition caused by a severe shortage or absence of growth hormone. Growth hormone is a protein that is necessary for the normal growth of the body's bones and tissues. Because they do not have enough of this hormone, people with isolated growth hormone deficiency commonly experience a failure to grow at the expected rate and have unusually short stature. This condition is usually apparent by early childhood.
There are four types of isolated growth hormone deficiency differentiated by the severity of the condition, the gene involved, and the inheritance pattern.
Isolated growth hormone deficiency type IA is caused by an absence of growth hormone and is the most severe of all the types. In people with type IA, growth failure is evident in infancy as affected babies are shorter than normal at birth.
People with isolated growth hormone deficiency type IB produce very low levels of growth hormone. As a result, type IB is characterized by short stature, but this growth failure is typically not as severe as in type IA. Growth failure in people with type IB is usually apparent in early to mid-childhood.
Individuals with isolated growth hormone deficiency type II have very low levels of growth hormone and short stature that varies in severity. Growth failure in these individuals is usually evident in early to mid-childhood. It is estimated that nearly half of the individuals with type II have underdevelopment of the pituitary gland (pituitary hypoplasia). The pituitary gland is located at the base of the brain and produces many hormones, including growth hormone.
Isolated growth hormone deficiency type III is similar to type II in that affected individuals have very low levels of growth hormone and short stature that varies in severity. Growth failure in type III is usually evident in early to mid-childhood. People with type III may also have a weakened immune system and are prone to frequent infections. They produce very few B cells, which are specialized white blood cells that help protect the body against infection (agammaglobulinemia).
Source: MedlinePlus Genetics, U.S. National Library of Medicine
This information is educational and is not medical advice.